logo-loader

Amryt Pharma generates 'significant' top line and bottom line metrics in 1Q of this year

Last updated: 14:44 11 May 2020 EDT, First published: 09:44 11 May 2020 EDT

Amryt Pharma PLC (LON:AMYT) CEO Joe Wiley tells Proactive the commercial-stage biopharmaceutical company's 1Q revenues rose by 30% to US$44.6mln from US$34.3mln in the corresponding period of 2019.

Wiley says it's also the first time the group has become EBITDA positive, generating $4.6M in EBITDA and cash of $6.2M.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

57 minutes ago